Baillie Gifford & Co’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.9M | Sell |
3,276,051
-74,840
| -2% | -$842K | 0.03% | 164 |
|
|
2025
Q1 | $19.1M | Sell |
3,350,891
-6,495
| -0.2% | -$37K | 0.02% | 182 |
|
|
2024
Q4 | $33M | Sell |
3,357,386
-1,195
| -0% | -$11.7K | 0.03% | 165 |
|
|
2024
Q3 | $27.4M | Sell |
3,358,581
-131,067,285
| -98% | -$1.07B | 0.02% | 167 |
|
|
2024
Q2 | $44.9M | Sell |
134,425,866
-98,573,807
| -42% | -$33M | 0.04% | 145 |
|
|
2024
Q1 | $270M | Sell |
232,999,673
-3,292,510
| -1% | -$3.82M | 0.21% | 89 |
|
|
2023
Q4 | $399M | Sell |
236,292,183
-2,516,640
| -1% | -$4.25M | 0.32% | 70 |
|
|
2023
Q3 | $432M | Sell |
238,808,823
-2,272,582
| -0.9% | -$4.11M | 0.39% | 57 |
|
|
2023
Q2 | $448M | Sell |
241,081,405
-1,786,855
| -0.7% | -$3.32M | 0.38% | 59 |
|
|
2023
Q1 | $323M | Sell |
242,868,260
-1,308,383
| -0.5% | -$1.74M | 0.29% | 76 |
|
|
2022
Q4 | $413M | Buy |
244,176,643
+40,099,800
| +20% | +$67.8M | 0.43% | 64 |
|
|
2022
Q3 | $637M | Sell |
204,076,843
-1,250,943
| -0.6% | -$3.9M | 0.66% | 41 |
|
|
2022
Q2 | $489M | Buy |
205,327,786
+37,575,106
| +22% | +$89.4M | 0.5% | 57 |
|
|
2022
Q1 | $676M | Buy |
167,752,680
+58,302,509
| +53% | +$235M | 0.47% | 59 |
|
|
2021
Q4 | $910M | Buy |
109,450,171
+18,447,361
| +20% | +$153M | 0.5% | 57 |
|
|
2021
Q3 | $1.05B | Buy |
+91,002,810
| New | +$1.05B | 0.55% | 51 |
|